Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial - Concepedia

Concepedia

Publication | Open Access

Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial

DOI Full Paper Access

55

Citations

25

References

2014

Year

Magnus Tobiasson, I Dybedahl, Mette Skov Holm, Mohsen Karimi, Lena Brandefors, Hege Garelius, Michael Grövdal, Inge Høgh Dufva, Kirsten Grønbæk, Monika Jansson,

Blood Cancer Journal

References

	Year	Citations

Page 1